UPCOMING SESSIONS in ET
Mon, May 11, 2026
10:00 – 11:00 PM UTC
Getting Your Meds Right: Small Details That Can Make a Big Difference Dr. Stacey Goodman Click To Register
UPCOMING SESSIONS in ET
Mon, May 11, 2026 · 10:00 – 11:00 PM UTC
Getting Your Meds Right: Small Details That Can Make a Big Difference
Dr. Stacey Goodman
Click To Register
View all sessions
Nov 26, 2015
Transthyretin (TTR) amyloidosis (ATTR amyloidosis) is a multisystemic, multigenotypic disease resulting from deposition of insoluble ATTR amyloid fibrils in various…
Nov 11, 2015
In immunoglobulin light chain (AL) amyloidosis, amyloid fibril deposits, derived from immunoglobulin light chains produced by a clonal plasma cell dyscrasia,…
Oct 21, 2015
Immunoglobulin light chain (AL) amyloidosis, the most common of the systemic amyloidosis, is characterized by the deposition of amyloid fibrils that derive from the…
Oct 21, 2015
Immunoglobulin light chain amyloidosis is the most common type of systemic amyloidosis. Hematopoietic stem cell transplantation (HCT) is an effective treatment…
Oct 13, 2015
The purpose of the study was to describe the main clinical and epidemiologic characteristics, treatment options, and outcome in a large series of patients with…
Sep 29, 2015
The liver has become an increasingly interesting target for oligonucleotide therapy. Mutations of the gene encoding transthyretin (TTR), expressed in vast amounts…
Sep 14, 2015
Amyloidosis is a disease in which proteins misfold, aggregate into fibrils, and deposit extracellularly disrupting organ architecture and function. There are two…